Phreesia, Inc. (PHR)
Stock analysis · NYSE · Healthcare · Medical - Healthcare Information Services
Phreesia, Inc. (PHR) is a publicly traded company in the Healthcare sector. Latest price: $12.53. Market cap $777.75M. Trailing PE 72.76. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About Phreesia, Inc.
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via s…
Valuation
| P/E (TTM) | 72.76× |
|---|---|
| P/S (TTM) | 1.53× |
| P/B | 2.09× |
| P/FCF (TTM) | 10.03× |
| EV / EBITDA | 13.77× |
| EV / Sales | 1.52× |
| Earnings Yield | 1.35% |
| Free Cash Flow Yield | 9.97% |
Fundamentals
| Enterprise Value | $772.75M |
|---|---|
| Revenue (TTM) | $507.79M |
| Net Income (TTM) | $10.48M |
| Free Cash Flow (TTM) | $121.04M |
| Net Debt | -$5.00M |
| Working Capital | $109.67M |
| Gross Margin | 63.55% |
| Operating Margin | 3.19% |
| Net Margin | 2.06% |
| Return on Equity | 3.01% |
| Return on Invested Capital | 3.18% |
Peers
Recent News
- Head-To-Head Comparison: Phreesia (NYSE:PHR) & National Research (NASDAQ:NRC)
- Phreesia's Michael Rasbury Named to Becker's 2026 List of Rising Stars: Healthcare Leaders Under 40
- Phreesia Named to TIME's 2026 List of the World's Top HealthTech Companies
- Phreesia (NYSE:PHR) General Counsel Allison Hoffman Sells 6,662 Shares of Stock
- Phreesia's ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace
Related
Browse more tickers: sitemap